Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
The Role of Next-Generation Sequencing in the Management of Patients with Suspected Non-Ischemic Cardiomyopathy after Syncope or Termination of Sudden Arrhythmic DeathGenes, 2024-01, Vol.15 (1), p.72 [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2073-4425 ;EISSN: 2073-4425 ;DOI: 10.3390/genes15010072 ;PMID: 38254962Full text available |
|
2 |
Material Type: Article
|
A case of infantile Barth syndrome with severe heart failure: Importance of splicing variants in the TAZ geneMolecular genetics & genomic medicine, 2023-07, Vol.11 (7), p.e2190-n/a [Peer Reviewed Journal]2023 The Authors. published by Wiley Periodicals LLC. ;2023 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC. ;2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2324-9269 ;EISSN: 2324-9269 ;DOI: 10.1002/mgg3.2190 ;PMID: 37186429Full text available |
|
3 |
Material Type: Newsletter Article
|
Tenaya Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business UpdateNews Bites US - NASDAQ, 2023Copyright News Bites Pty Ltd Nov 13, 2023Digital Resources/Online E-Resources |
|
4 |
Material Type: Newsletter Article
|
Tenaya Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business UpdateNews Bites US - NASDAQ, 2023Copyright News Bites Pty Ltd Nov 10, 2023Digital Resources/Online E-Resources |
|
5 |
Material Type: Newsletter Article
|
Tenaya Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business UpdateNews Bites US - NASDAQ, 2023Copyright News Bites Pty Ltd Nov 9, 2023Digital Resources/Online E-Resources |
|
6 |
Material Type: Newsletter Article
|
Monthly: Tenaya Therapeutics (TNYA: $2.55) drops 38% on high volatility in September 2023News Bites US - NASDAQ, 2023Copyright News Bites Pty Ltd Oct 2, 2023Digital Resources/Online E-Resources |
|
7 |
Material Type: Newsletter Article
|
Tenaya Therapeutics to Present Data for TN-301 and TN-201 at Upcoming Medical ConferencesNASDAQ OMX's News Release Distribution Channel, 2023GlobeNewswire, Inc.Digital Resources/Online E-Resources |
|
8 |
Material Type: Newsletter Article
|
Tenaya Therapeutics (TNYA: $4.59) drops 1.9% on slipping relative strength; -9c [1.9%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 3, 2024Digital Resources/Online E-Resources |
|
9 |
Material Type: Newsletter Article
|
Tenaya Therapeutics (TNYA: $4.68) gains 3.1%; +14c [3.1%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 2, 2024Digital Resources/Online E-Resources |
|
10 |
Material Type: Newsletter Article
|
Tenaya Therapeutics (TNYA: $4.54) jumps 5.3%; +23c [5.3%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd Apr 30, 2024Digital Resources/Online E-Resources |
|
11 |
Material Type: Newsletter Article
|
Weekly: Tenaya Therapeutics (TNYA: $4.31) keeps sliding: down 18% in 4 weeks; -92c [17.6%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd Apr 29, 2024Digital Resources/Online E-Resources |
|
12 |
Material Type: Newsletter Article
|
Tenaya Therapeutics (TNYA: $4.31) climbs 2.1%; +9c [2.1%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd Apr 27, 2024Digital Resources/Online E-Resources |
|
13 |
Material Type: Newsletter Article
|
Tenaya Therapeutics (TNYA: $4.23) drops to three-month low; -15c [3.4%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd Apr 26, 2024Digital Resources/Online E-Resources |
|
14 |
Material Type: Newsletter Article
|
Tenaya Therapeutics (TNYA: $4.38) drops 1.6% on slipping relative strength; -7c [1.6%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd Apr 25, 2024Digital Resources/Online E-Resources |
|
15 |
Material Type: Newsletter Article
|
Tenaya Therapeutics (TNYA: $4.45) increases; +2c [0.5%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd Apr 24, 2024Digital Resources/Online E-Resources |
|
16 |
Material Type: Newsletter Article
|
Tenaya Therapeutics (TNYA: $4.43) climbs 2.5%; +11c [2.5%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd Apr 23, 2024Digital Resources/Online E-Resources |
|
17 |
Material Type: Newsletter Article
|
Weekly: Tenaya Therapeutics (TNYA: $4.32) keeps sliding: down 17% in 3 weeks; -91c [17.4%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd Apr 22, 2024Digital Resources/Online E-Resources |
|
18 |
Material Type: Newsletter Article
|
Tenaya Therapeutics (TNYA: $4.32) increases; +3c [0.7%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd Apr 20, 2024Digital Resources/Online E-Resources |
|
19 |
Material Type: Newsletter Article
|
Tenaya Therapeutics (TNYA: $4.29) price 8.7% below VWAP, hits 35-day low; -1c [0.2%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd Apr 19, 2024Digital Resources/Online E-Resources |
|
20 |
Material Type: Newsletter Article
|
Tenaya Therapeutics (TNYA: $4.30) slides 3.6%, hits 34-day low; -16c [3.6%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd Apr 18, 2024Digital Resources/Online E-Resources |